Vivos continues to collaborate with its contract manufacturer, IsoTherapeutics, recently acquired by Telix (Nasdaq: TLX), to enhance production capacity for both Isopet ™ and RadioGel ®.

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...